ATENOLOL VERSUS PINDOLOL - SIDE-EFFECTS IN HYPERTENSION

被引:16
作者
FOERSTER, EC [1 ]
GREMINGER, P [1 ]
SIEGENTHALER, W [1 ]
VETTER, H [1 ]
VETTER, W [1 ]
机构
[1] UNIV MUNSTER,MED POLIKLIN,D-4400 MUNSTER,FED REP GER
关键词
D O I
10.1007/BF00543717
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:89 / 91
页数:3
相关论文
共 8 条
[1]   THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS [J].
CRUICKSHANK, JM .
AMERICAN HEART JOURNAL, 1980, 100 (02) :160-178
[2]  
FREWIN DB, 1980, NEW ZEAL MED J, V92, P389
[4]   A COMPARATIVE-STUDY BETWEEN 100MG ATENOLOL AND 20MG PINDOLOL SLOW-RELEASE IN ESSENTIAL-HYPERTENSION [J].
GREMINGER, P ;
VETTER, H ;
BOERLIN, HJ ;
HAVELKA, J ;
BAUMGART, P ;
WALGER, P ;
LUSCHER, T ;
SIEGENTHALER, W ;
VETTER, W .
DRUGS, 1983, 25 :37-41
[5]   DOUBLE-BLIND CROSSOVER COMPARISON OF PINDOLOL, METOPROLOL, ATENOLOL AND LABETALOL IN MILD TO MODERATE HYPERTENSION [J].
MCNEIL, JJ ;
LOUIS, WJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S163-S166
[6]  
WAALMANN.HJ, 1974, NEW ZEAL MED J, V80, P151
[7]  
WAALMANNING HJ, 1979, CLIN PHARMACOL THER, V25, P8